REVIEW
Published on 06 Mar 2019
Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials
doi 10.3389/fcvm.2019.00014
- 14,815 views
- 28 citations
- Frontiers in Cardiovascular Medicine
- Cardiovascular Epidemiology and Prevention
- Research Topics
- The Renaissance in Cardiovascular Disease Prevention – Ringing in the Post-Statin Era
The Renaissance in Cardiovascular Disease Prevention – Ringing in the Post-Statin Era
10k
Total downloads
41k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 28 Feb 2019
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
doi 10.3389/fcvm.2019.00016
- 11,930 views
- 129 citations
REVIEW
Published on 29 Jan 2019
Genetic Testing and Risk Scores: Impact on Familial Hypercholesterolemia
doi 10.3389/fcvm.2019.00005
- 8,754 views
- 31 citations
REVIEW
Published on 29 Jan 2019
Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries
doi 10.3389/fcvm.2018.00199
- 12,281 views
- 51 citations
Published in
Frontiers in Cardiovascular Medicine
- Cardiovascular Epidemiology and Prevention
Impact
- 41kTopic views
- 30kArticle views
- 10kArticle downloads